Peter W. Sonsini - Net Worth and Insider Trading
Peter W. Sonsini Net Worth
The estimated net worth of Peter W. Sonsini is at least $1.7 Billion dollars as of 2024-05-05. Peter W. Sonsini is the 10% Owner of NeueHealth Inc and owns about 182,444,280 shares of NeueHealth Inc (NEUE) stock worth over $1.1 Billion. Peter W. Sonsini is the 10% Owner of Adaptimmune Therapeutics PLC and owns about 102,478,668 shares of Adaptimmune Therapeutics PLC (ADAP) stock worth over $122 Million. Peter W. Sonsini is also the 10% Owner of Mirum Pharmaceuticals Inc and owns about 4,186,243 shares of Mirum Pharmaceuticals Inc (MIRM) stock worth over $108 Million. Besides these, Peter W. Sonsini also holds AVEO Pharmaceuticals Inc (AVEO) , Akouos Inc (AKUS) , Ardelyx Inc (ARDX) , Monte Rosa Therapeutics Inc (GLUE) , Trevi Therapeutics Inc (TRVI) , Mersana Therapeutics Inc (MRSN) , Inozyme Pharma Inc (INZY) , Marker Therapeutics Inc (MRKR) , Surface Oncology Inc (SURF) , Regulus Therapeutics Inc (RGLS) , Eargo Inc (EAR) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , TRACON Pharmaceuticals Inc (TCON) , Metacrine Inc (MTCR) , ARCA biopharma Inc (ABIO) , Genocea Biosciences Inc (GNCAQ) , Appian Corp (APPN) . Details can be seen in Peter W. Sonsini's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Peter W. Sonsini has not made any transactions after 2022-05-25 and currently still holds the listed stock(s).
Transaction Summary of Peter W. Sonsini
Peter W. Sonsini Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter W. Sonsini owns 53 companies in total, including Eargo Inc (EAR) , Metacrine Inc (MTCR) , and Mersana Therapeutics Inc (MRSN) among others .
Click here to see the complete history of Peter W. Sonsini’s form 4 insider trades.
Insider Ownership Summary of Peter W. Sonsini
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
EAR | Eargo Inc | 2020-10-20 | 10 percent owner |
MTCR | Metacrine Inc | 2021-12-22 | 10 percent owner |
MRSN | Mersana Therapeutics Inc | 2017-07-03 | 10 percent owner |
2020-07-28 | 10 percent owner | ||
2022-05-25 | 10 percent owner | ||
2020-07-23 | 10 percent owner | ||
2020-07-09 | 10 percent owner | ||
2020-06-30 | 10 percent owner | ||
2020-06-19 | 10 percent owner | ||
2018-04-23 | 10 percent owner | ||
2022-04-11 | 10 percent owner | ||
2020-03-11 | 10 percent owner | ||
2015-03-11 | 10 percent owner | ||
2020-02-06 | 10 percent owner | ||
2020-01-29 | 10 percent owner | ||
2020-01-24 | 10 percent owner | ||
2020-12-04 | 10 percent owner | ||
2016-07-18 | 10 percent owner | ||
2019-11-06 | 10 percent owner | ||
2019-10-30 | 10 percent owner | ||
2019-07-22 | 10 percent owner | ||
2019-06-07 | 10 percent owner | ||
2018-12-07 | 10 percent owner | ||
2021-03-16 | 10 percent owner | ||
2018-05-01 | 10 percent owner | ||
2018-03-27 | 10 percent owner | ||
2018-03-09 | 10 percent owner | ||
2018-02-26 | 10 percent owner | ||
2017-11-27 | 10 percent owner | ||
2015-09-30 | 10 percent owner | ||
2018-01-01 | 10 percent owner | ||
2017-11-20 | 10 percent owner | ||
2017-06-29 | director | ||
2016-12-19 | 10 percent owner | ||
2016-07-29 | 10 percent owner | ||
2015-10-14 | 10 percent owner | ||
2014-08-06 | 10 percent owner | ||
2021-03-15 | 10 percent owner | ||
2018-12-07 | 10 percent owner | ||
2021-04-08 | 10 percent owner | ||
2021-01-01 | 10 percent owner | ||
2021-06-28 | 10 percent owner | ||
2020-12-09 | 10 percent owner | ||
2021-07-29 | director & 10 percent owner | ||
2022-02-03 | 10 percent owner | ||
2021-07-21 | 10 percent owner | ||
2021-09-30 | 10 percent owner | ||
2021-06-28 | 10 percent owner | ||
2022-06-08 | 10 percent owner | ||
2022-08-03 | 10 percent owner | ||
2020-03-11 | 10 percent owner | ||
2018-01-19 | 10 percent owner | ||
2021-07-21 | 10 percent owner |
Peter W. Sonsini Latest Holdings Summary
Peter W. Sonsini currently owns a total of 21 stocks. Among these stocks, Peter W. Sonsini owns 182,444,280 shares of NeueHealth Inc (NEUE) as of June 28, 2021, with a value of $1.1 Billion and a weighting of 68.62%. Peter W. Sonsini owns 102,478,668 shares of Adaptimmune Therapeutics PLC (ADAP) as of January 24, 2020, with a value of $122 Million and a weighting of 7.34%. Peter W. Sonsini also owns 4,186,243 shares of Mirum Pharmaceuticals Inc (MIRM) as of July 22, 2019, with a value of $108 Million and a weighting of 6.51%. The other 18 stocks AVEO Pharmaceuticals Inc (AVEO) , Akouos Inc (AKUS) , Ardelyx Inc (ARDX) , Monte Rosa Therapeutics Inc (GLUE) , Trevi Therapeutics Inc (TRVI) , Mersana Therapeutics Inc (MRSN) , Inozyme Pharma Inc (INZY) , Marker Therapeutics Inc (MRKR) , Surface Oncology Inc (SURF) , Regulus Therapeutics Inc (RGLS) , Eargo Inc (EAR) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , TRACON Pharmaceuticals Inc (TCON) , Metacrine Inc (MTCR) , ARCA biopharma Inc (ABIO) , Genocea Biosciences Inc (GNCAQ) , Appian Corp (APPN) have a combined weighting of 17.54% among all his current holdings.
Latest Holdings of Peter W. Sonsini
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
NEUE | NeueHealth Inc | 2021-06-28 | 182,444,280 | 6.25 | 1,140,276,750 |
ADAP | Adaptimmune Therapeutics PLC | 2020-01-24 | 102,478,668 | 1.19 | 121,949,615 |
MIRM | Mirum Pharmaceuticals Inc | 2019-07-22 | 4,186,243 | 25.84 | 108,172,519 |
AVEO | AVEO Pharmaceuticals Inc | 2020-06-19 | 3,952,958 | 15.00 | 59,294,370 |
AKUS | Akouos Inc | 2020-06-30 | 4,294,207 | 13.29 | 57,070,011 |
ARDX | Ardelyx Inc | 2016-07-18 | 5,331,039 | 8.72 | 46,486,660 |
GLUE | Monte Rosa Therapeutics Inc | 2021-06-28 | 7,692,298 | 5.65 | 43,461,484 |
TRVI | Trevi Therapeutics Inc | 2022-04-11 | 11,370,376 | 3.02 | 34,338,536 |
MRSN | Mersana Therapeutics Inc | 2017-07-03 | 8,140,138 | 3.46 | 28,164,877 |
INZY | Inozyme Pharma Inc | 2020-07-28 | 2,437,689 | 4.74 | 11,554,646 |
MRKR | Marker Therapeutics Inc | 2021-03-16 | 1,071,429 | 4.22 | 4,521,430 |
SURF | Surface Oncology Inc | 2018-04-23 | 3,312,877 | 1.07 | 3,544,778 |
RGLS | Regulus Therapeutics Inc | 2020-12-04 | 645,106 | 2.65 | 1,709,531 |
EAR | Eargo Inc | 2020-10-20 | 326,001 | 2.57 | 837,823 |
ILIU | Interleukin Genetics Inc | 2016-07-29 | 55,418,811 | 0.00 | 249,385 |
AKAOQ | Achaogen Inc | 2016-12-19 | 5,215,128 | 0.03 | 130,378 |
TCON | TRACON Pharmaceuticals Inc | 2018-03-27 | 17,330 | 1.86 | 32,234 |
MTCR | Metacrine Inc | 2021-12-22 | 2,563,257 | 0.00 | 3,589 |
ABIO | ARCA biopharma Inc | 2018-02-26 | 0 | 3.26 | 0 |
GNCAQ | Genocea Biosciences Inc | 2022-05-25 | 0 | 0.00 | 0 |
APPN | Appian Corp | 2017-11-27 | 0 | 31.98 | 0 |
Holding Weightings of Peter W. Sonsini
Peter W. Sonsini Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter W. Sonsini has made a total of 1 transactions in NeueHealth Inc (NEUE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in NeueHealth Inc is the acquisition of 1,944,444 shares on June 28, 2021, which cost Peter W. Sonsini around $35 Million.
According to the SEC Form 4 filings, Peter W. Sonsini has made a total of 1 transactions in Adaptimmune Therapeutics PLC (ADAP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Adaptimmune Therapeutics PLC is the acquisition of 7,500,000 shares on January 24, 2020, which cost Peter W. Sonsini around $5 Million.
According to the SEC Form 4 filings, Peter W. Sonsini has made a total of 1 transactions in Mirum Pharmaceuticals Inc (MIRM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Mirum Pharmaceuticals Inc is the acquisition of 450,000 shares on July 22, 2019, which cost Peter W. Sonsini around $7 Million.
More details on Peter W. Sonsini's insider transactions can be found in the Insider Trading History of Peter W. Sonsini table.Insider Trading History of Peter W. Sonsini
- 1
Peter W. Sonsini Trading Performance
GuruFocus tracks the stock performance after each of Peter W. Sonsini's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter W. Sonsini is 5.15%. GuruFocus also compares Peter W. Sonsini's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter W. Sonsini within 3 months outperforms 24 times out of 45 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Peter W. Sonsini's insider trading performs compared to the benchmark.
Performance of Peter W. Sonsini
Peter W. Sonsini Ownership Network
Ownership Network List of Peter W. Sonsini
Ownership Network Relation of Peter W. Sonsini
Peter W. Sonsini Owned Company Details
What does Eargo Inc do?
Who are the key executives at Eargo Inc?
Peter W. Sonsini is the 10 percent owner of Eargo Inc. Other key executives at Eargo Inc include Chief Accounting Officer Mark Thorpe , Chief Operating Officer William Brownie , and Chief Financial Officer Adam Laponis .
Eargo Inc (EAR) Insider Trades Summary
Over the past 18 months, Peter W. Sonsini made no insider transaction in Eargo Inc (EAR). Other recent insider transactions involving Eargo Inc (EAR) include a net sale of 2,012 shares made by William Brownie , a net sale of 725 shares made by Adam Laponis , and a net sale of 92 shares made by Mark Thorpe .
In summary, during the past 3 months, insiders sold 0 shares of Eargo Inc (EAR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,799 shares of Eargo Inc (EAR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,799 shares.
Eargo Inc (EAR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eargo Inc Insider Transactions
Peter W. Sonsini Mailing Address
Above is the net worth, insider trading, and ownership report for Peter W. Sonsini. You might contact Peter W. Sonsini via mailing address: 2855 Sand Hill Road, Menlo Park Ca 94025.